First Time Loading...

Bruker Corp
NASDAQ:BRKR

Watchlist Manager
Bruker Corp Logo
Bruker Corp
NASDAQ:BRKR
Watchlist
Price: 80.97 USD 0.47% Market Closed
Updated: Apr 27, 2024
Section:
 

Relative Value

The Relative Value of one BRKR stock under the Base Case scenario is 110.24 USD. Compared to the current market price of 80.97 USD, Bruker Corp is Undervalued by 27%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BRKR Relative Value
Base Case
110.24 USD
Undervaluation 27%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4
P/S
P/S
Price to Sales
4
vs History
41
vs Industry
47
Median 3Y
4
Median 5Y
3.8
Industry
3.9
Forward
3.5
More Details
27.5
P/E
P/E
Price to Earnings
27.5
vs History
92
vs Industry
25
Median 3Y
34.3
Median 5Y
36.3
Industry
30.3
Forward
30.5
More Details
33.6
P/OCF
P/OCF
Price to OCF
33.6
vs History
44
vs Industry
17
Median 3Y
34.9
Median 5Y
32.3
Industry
23.2
More Details
60.2
P/FCFE
P/FCFE
Price to FCFE
60.2
vs History
23
vs Industry
12
Median 3Y
51.4
Median 5Y
23.5
Industry
26.9
More Details
8.5
P/B
P/B
Price to Book Value
8.5
vs History
55
vs Industry
7
Median 3Y
9.5
Median 5Y
8.8
Industry
2.5
More Details
4.2
EV/S
EV/S
Enterprise Value to Sales
4.2
vs History
36
vs Industry
40
Median 3Y
4.2
Median 5Y
4
Industry
3.8
Forward
3.7
More Details
8.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.2
vs History
39
vs Industry
43
Median 3Y
8.2
Median 5Y
8
Industry
7.7
More Details
20.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.7
vs History
36
vs Industry
24
Median 3Y
19.7
Median 5Y
19.7
Industry
16.8
Forward
18.5
More Details
25.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25.5
vs History
38
vs Industry
23
Median 3Y
23.8
Median 5Y
24.2
Industry
22
Forward
21.3
More Details
35.5
EV/OCF
EV/OCF
Enterprise Value to OCF
35.5
vs History
42
vs Industry
13
Median 3Y
35.4
Median 5Y
33.4
Industry
21.1
More Details
51.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
51.1
vs History
46
vs Industry
13
Median 3Y
53.6
Median 5Y
50.3
Industry
27.6
More Details
3.5
EV/IC
EV/IC
Enterprise Value to IC
3.5
vs History
69
vs Industry
29
Median 3Y
4
Median 5Y
3.8
Industry
2.4
More Details

Multiples Across Competitors

BRKR Competitors Multiples
Bruker Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Bruker Corp
NASDAQ:BRKR
11.8B USD 4 27.5 20.7 25.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
221.8B USD 5.2 37 22.8 33.5
US
Danaher Corp
NYSE:DHR
182.6B USD 4.2 22.6 16.5 20.3
US
IQVIA Holdings Inc
NYSE:IQV
42.6B USD 2.8 31.4 17 26.2
CH
Lonza Group AG
SIX:LONN
38.1B CHF 5.7 58.2 20 29.3
US
Agilent Technologies Inc
NYSE:A
40.4B USD 6 32.7 26.1 31.4
KR
Samsung Biologics Co Ltd
KRX:207940
54.8T KRW 14.8 63.9 33.7 48.5
US
Mettler-Toledo International Inc
NYSE:MTD
26.7B USD 7 33.8 23.6 26.3
US
West Pharmaceutical Services Inc
NYSE:WST
26.5B USD 9 44.6 30.5 36.5
IE
ICON PLC
NASDAQ:ICLR
25.4B USD 3.1 41.5 17.6 27.5
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.1 75.4 32.4 53.2

See Also

Summary
BRKR intrinsic value, competitors valuation, and company profile.
DCF Valuation
BRKR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BRKR stock valuation using valuation multiples.
Wall Street Estimates
BRKR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BRKR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.